Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study record now displays the most recent update dates, indicating routine maintenance to refresh the record. These changes are metadata about maintenance rather than substantive updates to the study design, results, or eligibility criteria.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, reflecting a small update to the page metadata.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision bumped from v3.6.2 to v3.6.3 on the page, indicating a software update. The study content and visible information for NCT01874353 appear unchanged.SummaryDifference0.0%

- Check42 days agoChange DetectedA new bibliographic citation was added documenting the adverse-event profile in BRCA-mutated, platinum-sensitive relapsed ovarian cancer (SOLO2 trial) from Int J Gynecol Cancer, 2026. The page revision tag was updated from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check57 days agoChange DetectedThe Study Details page now includes user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating 'No longer looking for participants.' The Intervention/Treatment heading has been standardized (replacing 'Intervention / Treatment'), and the page footer revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, marking a new version of the page for tracking updates. This change is a non-substantive metadata update and does not modify the study details or results.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.